Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Practice Guidelines as Topic × 1 year × Clear all

Sponsor

Conditions

Lung Neoplasms 17 Hematologic Neoplasms 11 Prostatic Neoplasms 8 Breast Neoplasms 8 Hematopoietic and Lymphatic System Neoplasm 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Breast Carcinoma In Situ 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Multiple Myeloma 4 Anatomic Stage I Breast Cancer AJCC v8 4 Stomach Neoplasms 3 Melanoma 3 Malignant Solid Neoplasm 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Hematopoietic and Lymphoid System Neoplasm 3 Head and Neck Carcinoma 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Mouth Neoplasms 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2

Interventions

Cyclophosphamide 37 venetoclax 27 fludarabine 27 Dexamethasone 26 pembrolizumab 20 Rituximab 17 Gemcitabine 16 pomalidomide 14 Cytarabine 14 Lenalidomide 12 Nivolumab 11 fludarabine phosphate 10 carfilzomib 10 Temozolomide 10 Etoposide 10 Azacitidine 10 Injections 9 Calcium Dobesilate 9 obinutuzumab 8 glofitamab 8 daratumumab 8 Cisplatin 7 Capecitabine 7 Bevacizumab 7 zanubrutinib 6 selinexor 6 ruxolitinib 6 ibrutinib 6 cemiplimab 6 Decitabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡